Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02040025

Enrollment

Registered

2014-01-20

Start date

2014-04-30

Completion date

2016-10-31

Last updated

2020-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

hypertension, diabetes mellitus, hemoglobin A1C, peripheral vascular resistance, EECP, Blood pressure, angiogenesis, Coronary Artery Disease, Coronary Disease, Heart Diseases, Cardiovascular Diseases

Brief summary

The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Age equal to or greater than 18 2. Diagnosis of Type 1 or Type 2 diabetes mellitus 3. Prescribed EECP therapy in the DGMC EECP clinic 4. Medically cleared for EECP therapy 5. TRICARE beneficiary

Exclusion criteria

1\. DGMC EECP clinic patient withou a diagnosis of Type 1 or Type 2 diabetes mellitus

Design outcomes

Primary

Measure	Time frame
Change from baseline in TCOM (Transcutaneous oximetry measurement) values	At baseline & post intervention, expected to be on average 30 minutes

Secondary

Measure	Time frame
Change from baseline in hemoglobin A1C laboratory values	At baseline & post intervention, expected to be on average 30 minutes

Countries

United States

Outcome results